2022 annual financial data
Humacyte 2022 Operating margin
Direct answer
Operating margin was -5,404.35%.
Operating income was -84,578,000 USD and net income was -11,965,000 USD.
Operating cash flow was -71,129,000 USD.
Get free Humacyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,565,000 USD
- Operating income
- -84,578,000 USD
- Net income
- -11,965,000 USD
- Operating cash flow
- -71,129,000 USD